Vibolic 300

Vibolic 300: Advanced Hepatoprotective Therapy (Ursodeoxycholic Acid 300mg)

Vibolic 300 is a premium liver-corrective medication containing Ursodeoxycholic Acid (UDCA) 300mg. Developed by Vibrella Pharmaceuticals, this tablet is a naturally occurring bile acid used to manage a variety of hepatobiliary (liver and gallbladder) disorders. Vibolic 300 works by improving bile flow and protecting liver cells from the damaging effects of toxic bile acids.

Key Therapeutic Benefits

• Dissolution of Gallstones: Effectively helps in dissolving small to medium-sized radiolucent gallstones primarily composed of cholesterol.

• Liver Cell Protection: Acts as a powerful hepatoprotective agent, shielding liver cells (hepatocytes) from oxidative stress and injury caused by toxic bile acids.

• Management of PBC: Clinically indicated for the treatment of Primary Biliary Cholangitis (PBC), helping to delay the progression of liver damage.

• Cholesterol Regulation: Reduces the amount of cholesterol produced by the liver and absorbed by the intestines, helping to maintain a healthy bile balance.

• Cystic Fibrosis Support: Helps manage liver and biliary complications in patients with cystic fibrosis.

Why Choose Vibolic 300?

Vibolic 300 is formulated for high bioavailability and consistent therapeutic action. By thinning the bile and promoting its flow, it reduces "biliary sludge" and prevents the formation of new stones, making it a non-surgical alternative for eligible patients.

Product Specifications

Usage & Safety

Directions for Use: Swallow the tablet whole with water or milk, preferably after a meal. Do not crush or chew. The dosage is typically based on body weight and the specific condition being treated, as advised by your physician.

Important Note: Avoid taking antacids containing aluminum simultaneously with Vibolic 300, as they can interfere with the medication's absorption.